drugset / Trial / NCT06653608

Clinical Efficacy of Novel Jasminum-based Calcium Hydroxide Medicament

NCT06653608

Non-randomizedParallel-groupTriple-blindTreatment

Summary

A triple-blind, parallel group, randomized trial with an allocation ratio of 1:1. Participants randomly allocated into two groups A and B. In group A, nano-reinforced calcium hydroxide medicament was utilized while in group B, calcium hydroxide medicament without nanoparticles was used. Post-operative pain was assessed after 4 hours, 24 hours, 48 hours, 72 hours, 96 hours.

Timeline

Start
2024-04-24
Primary completion
2024-09-25
Completion
2024-09-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium Hydroxide Other / unclassified
Subject group A, C polysaccharide meningococcal and type b haemophilus Influenzal Conjugate vaccine Vaccine